AI CURATED HOT STORY · 10/21/2026
OpenAI, in collaboration with Scripps Research and PerturbAI, deployed 1,946 GPT-Rosalind-5.5-based AI agents to analyze a mouse whole-brain CRISPR map in just 32 minutes, compressing months of manual work into minutes. This breakthrough validated the feasibility of multi-agent systems for large-scale biological data analysis, successfully reproducing 48 out of 55 published findings.
The core innovation is a "one-gene-one-agent" parallel architecture, where each agent independently processes specific gene perturbation data and links it to scientific literature. Compared to single-model approaches, this structure increased citation density by approximately 700 times, significantly strengthening evidence support. Blind reviews showed that human experts preferred AI-generated reports 75% of the time, demonstrating the system's ability to reason beyond its training cutoff.
This milestone marks a shift from AI as an auxiliary tool to an autonomous research partner, offering a new paradigm for accelerating discoveries in complex neurological diseases like Alzheimer's and Parkinson's. By efficiently connecting gene perturbations with vast literature, the method promises to shorten drug development cycles and reshape biomedical data mining workflows.